INSIGHTS ON QUALITY ASSURANCE

• Device Design For Usability And Risk Reduction

  Growing use of large‑volume subcutaneous therapies is increasing demand for wearable injectors that reduce user error, simplify preparation, and enhance safety through human‑factors‑focused design.

• Predicting Performance Of Lotions Through Rheological Characterization

  Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.

• The Future Of CGT: Integrating Digitalization With Regulatory Readiness

  Explore how cell and gene therapy manufacturers are scaling from batch‑of‑one to commercial supply while staying compliant, digital, and efficient, as well as strategies to strengthen quality.

• Operational Readiness Frameworks For Pharma And Biotech

  Achieving top performance in life sciences requires a continuous journey from Operational Readiness (OR) to sustained Operational Excellence (OE), ensuring safe startup and long-term efficiency.

• Sustainability In Small Molecule API Manufacturing

  11/7/2025

  Redesigning chemical processes with green chemistry principles can cut emissions, reduce waste, and improve efficiency. See how smarter synthesis and digital tools enable sustainable API manufacturing.

• What Does Annex 1 Mean For Cryovial Filling?

  10/6/2025

  New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.

• Preparing Pharma Operations For An Autonomous Future

  2/6/2026

  Biopharma’s push for faster delivery is accelerating a shift from automated to autonomous manufacturing. Explore how deeper connectivity and self‑optimizing systems are shaping the next frontier.

• How Iteration And Operational Readiness Accelerate Product-To-Patient

  5/20/2026

  See how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.

• Episodic Vs. Continuous Readiness: Which Operating Model Is Carrying Your Biotech Forward?

  5/11/2026

  Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.